Clinical Brief Series: Adjuvant immunotherapy for melanoma
Adjuvant immunotherapy has recently become a treatment option for patients with melanoma and sentinel lymph node biopsy (SLNB) plays a critical role in identifying the subset of patients at high risk of recurrence or relapse following complete resection who may benefit.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
A/Prof Victoria Atkinson
Dr Lisau202fBeecham
Duration
1 H